APA (7th ed.) Citation

S, S., R, Z., & RI, A. (2013). The impact of CYP3A5 and MDR1 polymorphisms on tacrolimus dosage requirements and trough concentrations in pediatric renal transplant recipients. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 24(6), 1125. https://doi.org/10.4103/1319-2442.121268

Chicago Style (17th ed.) Citation

S, Shilbayeh, Zmeili R, and Almardini RI. "The Impact of CYP3A5 and MDR1 Polymorphisms on Tacrolimus Dosage Requirements and Trough Concentrations in Pediatric Renal Transplant Recipients." Saudi Journal of Kidney Diseases and Transplantation : An Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia 24, no. 6 (2013): 1125. https://doi.org/10.4103/1319-2442.121268.

MLA (9th ed.) Citation

S, Shilbayeh, et al. "The Impact of CYP3A5 and MDR1 Polymorphisms on Tacrolimus Dosage Requirements and Trough Concentrations in Pediatric Renal Transplant Recipients." Saudi Journal of Kidney Diseases and Transplantation : An Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia, vol. 24, no. 6, 2013, p. 1125, https://doi.org/10.4103/1319-2442.121268.